GRPR versus PSMA: expression profiles during prostate cancer progression demonstrate the added value of GRPR-targeting theranostic approaches

GRPR versus PSMA: expression profiles during prostate cancer progression demonstrate the added value of GRPR-targeting theranostic approaches

IntroductionCentral to targeted radionuclide imaging and therapy of prostate cancer (PCa) are prostate-specific membrane antigen (PSMA)-targeting radiopharmaceuticals. Gastrin-releasing peptide receptor (GRPR) targeting has been proposed as a potential additional approach for PCa theranostics. The a...

Full description

Bibliographic Details
Main Authors: Marjolein Verhoeven, Eline A. M. Ruigrok, Geert J. L. H. van Leenders, Lilian van den Brink, Hayri E. Balcioglu, Wytske M. van Weerden, Simone U. Dalm
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Oncology
Subjects:
gastrin-releasing peptide receptor (GRPR)
prostate-specific membrane antigen (PSMA)
prostate cancer
NeoB
PSMA-617
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1199432/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1199432/full

Similar Items